Your browser doesn't support javascript.
loading
Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy.
Takagi, Toshio; Yoshida, Kazuhiko; Kondo, Tsunenori; Fukuda, Hironori; Ishihara, Hiroki; Kobayashi, Hirohito; Iizuka, Junpei; Ishida, Hideki; Tanabe, Kazunari.
Afiliação
  • Takagi T; Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
  • Yoshida K; Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
  • Kondo T; Department of Urology, Tokyo Women's Medical University Medical Center East, Tokyo, Japan.
  • Fukuda H; Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
  • Ishihara H; Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
  • Kobayashi H; Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
  • Iizuka J; Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
  • Ishida H; Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
  • Tanabe K; Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
Jpn J Clin Oncol ; 51(12): 1744-1750, 2021 Dec 01.
Article em En | MEDLINE | ID: mdl-34487184

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Imunológicos / Hipopituitarismo / Neoplasias Renais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Imunológicos / Hipopituitarismo / Neoplasias Renais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article